ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666850 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666850; 2) Community: the network communities that were significantly associated with the response to NSC 666850; 3) Molecule: the relationships between components within communities and NSC 666850; 4) MDR: the compounds that were significantly associated with the NSC 666850.

NSC Compound Enrichment Correlation
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0430505868034761 0.18749389
NSC 165572 Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- 0.0430505868034761 -0.11574473
NSC 176323 Camptothecin Derivative 0.0430505868034761 0.033380079
NSC 178248 Chlorozotocin 0.0430505868034761 -0.022315922
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0430505868034761 0.41248321
NSC 228120 Benzofurazan, 4-[(3-methoxyphenyl)thio]-7-nitro-, 3-oxide 0.0430505868034761 0.67285094
NSC 256926 HYRCANOSIDE 0.0430505868034761 0.35516194
NSC 270057 Hydroxypristimerin 0.0430505868034761 0.60812079
NSC 287069 Epicorazine A 0.0430505868034761 0.45751729
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.0430505868034761 0.13509218
Total:103  Current:91    [First] [Prev] [Next] [Last]